214 related articles for article (PubMed ID: 21375480)
1. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.
Vidal R; Pilar-Cuéllar F; dos Anjos S; Linge R; Treceño B; Vargas VI; Rodriguez-Gaztelumendi A; Mostany R; Castro E; Diaz A; Valdizán EM; Pazos A
Curr Pharm Des; 2011; 17(5):521-33. PubMed ID: 21375480
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?
Vidal R; Castro E; Pilar-Cuéllar F; Pascual-Brazo J; Díaz A; Rojo ML; Linge R; Martín A; Valdizán EM; Pazos A
Curr Pharm Des; 2014; 20(23):3751-62. PubMed ID: 24180399
[TBL] [Abstract][Full Text] [Related]
3. Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.
Pilar-Cuéllar F; Vidal R; Díaz A; Castro E; dos Anjos S; Pascual-Brazo J; Linge R; Vargas V; Blanco H; Martínez-Villayandre B; Pazos Á; Valdizán EM
Neural Plast; 2013; 2013():537265. PubMed ID: 23862076
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression.
Levy MJF; Boulle F; Steinbusch HW; van den Hove DLA; Kenis G; Lanfumey L
Psychopharmacology (Berl); 2018 Aug; 235(8):2195-2220. PubMed ID: 29961124
[TBL] [Abstract][Full Text] [Related]
5. [Depression and neuroplasticity].
Pitchot W; Polis M; Belachew S; Ansseau M
Rev Med Liege; 2008; 63(5-6):372-7. PubMed ID: 18669207
[TBL] [Abstract][Full Text] [Related]
6. [Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems].
Cassano P; Argibay P
Medicina (B Aires); 2010; 70(2):185-93. PubMed ID: 20447905
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
8. Translating the promise of 5HT
Murphy SE; de Cates AN; Gillespie AL; Godlewska BR; Scaife JC; Wright LC; Cowen PJ; Harmer CJ
Psychol Med; 2021 May; 51(7):1111-1120. PubMed ID: 32241310
[TBL] [Abstract][Full Text] [Related]
9. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
10. Serotonin receptors, type 4: a new hope?
Lucas G
Curr Drug Targets; 2009 Nov; 10(11):1085-95. PubMed ID: 19702554
[TBL] [Abstract][Full Text] [Related]
11. Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants.
Khushboo ; Siddiqi NJ; de Lourdes Pereira M; Sharma B
Mol Neurobiol; 2022 Jun; 59(6):3564-3584. PubMed ID: 35352302
[TBL] [Abstract][Full Text] [Related]
12. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
Arantes-Gonçalves F; Coelho R
Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
[TBL] [Abstract][Full Text] [Related]
13. Neuroplasticity-related mechanisms underlying the antidepressant-like effects of traditional herbal medicines.
Hirshler Y; Doron R
Eur Neuropsychopharmacol; 2017 Oct; 27(10):945-958. PubMed ID: 28807619
[TBL] [Abstract][Full Text] [Related]
14. The roles of neurotrophic factor and Wnt signaling in depression.
Voleti B; Duman RS
Clin Pharmacol Ther; 2012 Feb; 91(2):333-8. PubMed ID: 22205198
[TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular mechanisms in the long-term action of antidepressants.
Racagni G; Popoli M
Dialogues Clin Neurosci; 2008; 10(4):385-400. PubMed ID: 19170396
[TBL] [Abstract][Full Text] [Related]
16. Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression.
Wang YT; Wang XL; Feng ST; Chen NH; Wang ZZ; Zhang Y
Pharmacol Res; 2021 Sep; 171():105761. PubMed ID: 34242798
[TBL] [Abstract][Full Text] [Related]
17. [Affective disorders and antidepressant drugs: Therapeutic innovations].
Fakra E; Azorin JM; Adida M; Da Fonseca D; Kaladjian A; Pringuey D
Encephale; 2010 Dec; 36 Suppl 6():S183-7. PubMed ID: 21237354
[TBL] [Abstract][Full Text] [Related]
18. Tianeptine, an atypical pharmacological approach to depression.
Alamo C; García-Garcia P; Lopez-Muñoz F; Zaragozá C
Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(3):170-186. PubMed ID: 30612921
[TBL] [Abstract][Full Text] [Related]
19. Molecular Neurobiology and Promising New Treatment in Depression.
Jeon SW; Kim YK
Int J Mol Sci; 2016 Mar; 17(3):381. PubMed ID: 26999106
[TBL] [Abstract][Full Text] [Related]
20. CK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior.
Castello J; LeFrancois B; Flajolet M; Greengard P; Friedman E; Rebholz H
Mol Psychiatry; 2018 Apr; 23(4):872-882. PubMed ID: 29158580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
